A study which surveyed 121 subjects with acute and chronic disorders from differents sport activities.
The main objective of the present study is to demonstrate the efficacy of utilizing a novel non-invasive radiofrequency (RF) device in treatment of acute and chronic musculoskeletal disorders. The system is composed of a generator that distributes signals at a frequency of 500 kHz and maximum power of 324 W. The study surveyed 121 subjects (61 females, 60 males) between 18 and 58 years of age with acute and chronic disorders from different sports activities. The patients were divided into two groups, one consisted of 37 cases of acute disorders without previously treatments, and another consisted of 84 cases of chronic disorders treated by various traditional methods. The procedure began with capacitive mode with an electrode positioned on the area to be treated for 10 min., followed by another 10 minutes with a resistive electrode. The efficacy was monitored and evaluated by an independent observer using the Steinbroker classification for athletic activity and the visual analogue scale (VAS) from 0 to 10 where 0 corresponds to no pain and 10 to intolerable pain. The patients were treated for articular, muscular, and tendinous disorders. The clinical results indicate that TR- therapy is an effective method in the treatment of sports disorders of the musculoskeletal system.
The present study enrolled a total of 121 athletes involved in various disciplines. The patients were treated for acute (88 subjects) and chronic (33 subjects) disorders which could be additionally subdivided in: articular (in 46.3% of cases), muscular (in 37.2% of cases), and tendinous (in 16.5% of cases) disorders. The final results showed significant improvement in articular as well as muscular and tendinious disorders with a fast reduction of the pain, measured with VAS. The statistical processing of data results in a P value of <0.0001. Only 8 patients still presented functional limitation, due to a chronic disorder, but reported an overall improvement in pain symptoms. No adverse events were observed during the study.